On the Record · Cardinal Health
Cardinal Health acquisitions, on the record
The businesses Cardinal Health bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
CordisWord for word“Restructuring and employee severance costs during fiscal 2023 and 2022 were primarily related to the implementation of certain enterprise-wide cost-savings measures and the divestiture of the Cordis business.” 10-K for 2023 | divestiture | — | — |
naviHealthWord for word“• (Gain)/Loss on sale of equity interest in naviHealth was incurred in connection with the sale of our remaining equity interest in naviHealth in fiscal 2020.” 10-K for 2023 | divestiture | fiscal 2020 | — |
Specialty NetworksWord for word“On March 18, 2024, we completed the acquisition of Specialty Networks for a purchase price of $1.2 billion in cash, subject to certain adjustments.” 10-K for 2024 | acquisition | On March 18, 2024 | $1.2 billion in cash |
Advanced Diabetes Supply Group (ADS)Word for word“On April 1, 2025, we completed the acquisition of ADS, a diabetic medical supplies provider to patients in the home, for a purchase price of $1.1 billion in cash, subject to certain adjustments.” 10-K for 2025 | acquisition | On April 1, 2025 | $1.1 billion in cash |
GI Alliance (GIA)Word for word“On January 30, 2025, we completed the acquisition of a 73 percent ownership interest in GI Alliance ("GIA"), a management services organization ("MSO") primarily serving gastroenterologists, for a purchase price of approximately $2.8 billion in cash, subject to certain adjustments.” 10-K for 2025 | acquisition | On January 30, 2025 | approximately $2.8 billion in cash |
Urology AmericaWord for word“Additionally, on May 30, 2025, we, through GIA, completed the acquisition of Urology America, a urology management services organization, for a purchase price of $360 million in cash, subject to certain adjustments.” 10-K for 2025 | acquisition | on May 30, 2025 | $360 million in cash |
Integrated Oncology Network (ION)Word for word“On December 2, 2024, we completed the acquisition of ION, a physician-led independent community oncology network, for a purchase price of $1.1 billion in cash, subject to certain adjustments.” 10-K for 2025 | acquisition | On December 2, 2024 | $1.1 billion in cash |
Solaris HealthWord for word“On November 3, 2025, we, through The Specialty Alliance, completed the acquisition of Solaris Health, a urology MSO, for a purchase price of approximately $1.9 billion in cash, subject to certain adjustments.” 10-K for 2026 | acquisition | On November 3, 2025 | approximately $1.9 billion in cash |
ADSWord for word“In April 2025, we completed the acquisition of ADS, a diabetes medical supplies provider to patients in the home, for a purchase price of approximately $1.0 billion in cash.” 10-K for 2026 | acquisition | In April 2025 | approximately $1.0 billion in cash |
GIAWord for word“In January 2025, we completed the acquisition of 73 percent ownership interest in GIA, a gastroenterology management services organization now part of The Specialty Alliance, for a purchase price of approximately $2.8 billion in cash.” 10-K for 2026 | acquisition | In January 2025 | approximately $2.8 billion in cash |
IONWord for word“In December 2024, we completed the acquisition of ION, a physician-led independent community oncology network, for a purchase price of $1.1 billion in cash.” 10-K for 2026 | acquisition | In December 2024 | $1.1 billion in cash |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Cash received from selling businesses | Goodwill from acquisitions |
|---|---|---|---|
| 2016-06-30 | $3.61 billion | — | $2.12 billion |
| 2017-06-30 | $132 million | — | $64 million |
| 2018-06-30 | $6.14 billion | — | $3.34 billion |
| 2019-06-30 | $82 million | — | $52 million |
| 2020-06-30 | $0 | $0 | — |
| 2021-06-30 | $3 million | $0 | $2 million |
| 2022-06-30 | $22 million | $923 million | $14 million |
| 2023-06-30 | $10 million | $0 | $15 million |
| 2024-06-30 | $1.19 billion | $9 million | $790 million |
| 2025-06-30 | $5.25 billion | — | $4.97 billion |
Deal filings since 2016
- 2026-08-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-10-10 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-10-03 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-08-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-12-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-11-22 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-11-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-10-10 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-02-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-09-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-05-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-03-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-10-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-09-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-02-25 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-10-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-06-28 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-08-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-04-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-06-21 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Cardinal Health’s annual reports (10-K for 2026, 10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-08-11. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.